Hydrochlorothiazide/Quinapril Hydrochloride

氢氯噻嗪/盐酸喹那普利

Report date: 2023/02/03 20:00:25

Base Information

Drug NameHydrochlorothiazide/Quinapril Hydrochloride
Drug Alias NameQuinapril Hydrochloride/Hydrochlorothiazide盐酸喹那普利/氢氯噻嗪quinapril HCl/hydrochlorothiazideQuinapril Hydrochloride and HydrochlorothiazideQuinapril hydrochloride - hydrochlorothiazide +[7] 
ClassificationSmall molecules
Mechanisms of ActionThiazide-sensitive sodium-chloride cotransporter inhibitorsAngiotensin-converting enzyme inhibitors
TargetsThiazide-sensitive sodium-chloride cotransporterAngiotensin-converting enzyme
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1999/12/28
Country/TerritoryUnited States
CombinationsYes HydrochlorothiazideQuinapril Hydrochloride
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeC09BA06
Related LinksKEGG